GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma

作者：Peiyi Xie, Mengyuan Wu, Hui Wang, Bo Zhang, Zihao Zhang, Jiuliang Yan, Mincheng Yu, Qiang Yu, Yufei Zhao, Da Huang, Min Xu, Wenxin Xu, Hui Li, Yongfeng Xu, Yong‐Sheng Xiao, Lei Guo · 发表于：Oncogene · 年份：2024 · DOI：10.1038/s41388-024-03153-7 · 被引用次数：5 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cancer Mechanisms and Therapy、MicroRNA in disease regulation